instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
Top doctors fighting Ebola quickly used the case on Tuesday to press the message that people can recover from the potentially deadly disease if they seek proper care. Ebola is dangerous but it is also curable with correct treatment, said Dr. Jean-Jacques Muyembe, director of Congo's National Institute for Biomedical Research. "Ebola kills quickly and Ebola heals quickly. That's the message," said Muyembe, at a press conference in Goma. "These cases were detected very quickly. The husband was infected, he was at home for 10 days and his wife and son were infected," said Muyembe. "As soon as the response teams detected these cases, they brought them here to the treatment center. We gave them treatment that is effective and here in a short time both are cured." Muyembe said two new drugs "are now be used to treat Ebola patients because, according to the studies and the results we obtained in the lab, these are the two drugs that are effective." Muyembe and other scientists announced this week that preliminary results from two trials in Congo found two drugs made by Regeneron and the U.S. National Institutes of Health seem to be saving lives. Researchers said more study is needed to nail down how well those two compounds work. The drugs are antibodies that block Ebola. In the trial, significantly fewer people died among those given the Regeneron drug or the NIH's, about 30%, compared to those who received another treatment. Esperance Nabintu rejoiced that she and her young son had survived Ebola. "May the Lord be praised, I thank the Lord very much. I and my child were sick with Ebola, but God has just healed us. "My brothers, we must not doubt. Ebola exists, "said Nabintu, whose husband was the second Ebola victim to die in Goma. No other Ebola death has been detected since then. After a public announcement that Nabintu and her son, Ebenezer Fataki, 1, had recovered from Ebola, the response team accompanied the two former patients their home in the Kiziba area, where the medical team educated the residents about proper Ebola treatment. There is less danger that Ebola will spread through Goma, the capital of North Kivu province with more than 2 million inhabitants, because about 200 contacts and suspected cases have been identified and have received proper medication, said Muyembe. He said people arriving in Goma are being monitored at the city's entry points. "People who come from Beni and Butembo (nearby cities where there are many Ebola cases) must be carefully examined, "said Muyembe. "All of the 200 contacts we are following are doing well. We are waiting until the end of the 21-day surveillance period. We are at day 13, so there are still 8 days to go before we can say that Goma has won against Ebola." Health officials have also vaccinated tens of thousands of people in Congo and surrounding countries in an attempt to stop the outbreak, but the virus has now continued to spread for more than a year. Response efforts have been repeatedly hampered by attacks on health workers and continuing mistrust among the affected communities; many people in the region don't believe the virus is real and choose to stay at home when they fall ill, infecting those who care for them. ___ Follow Africa news at https://twitter.com/AP_Africa
answer:
2 Ebola patients in Congo "cured" with drugs, say doctors.

question:
The justices did not comment in refusing to review an appeals court ruling that upheld the law. Enforcement of the law had been on hold pending the legal challenge but will begin shortly, said Steve Pitt, general counsel to Kentucky Gov. Matt Bevin. The American Civil Liberties Union had challenged the law on behalf of Kentucky's lone remaining abortion clinic. The ACLU argued that "display and describe" ultrasound laws violate physicians' speech rights under the First Amendment. The federal appeals court in Cincinnati upheld the Kentucky law, but its sister court in Richmond, Virginia, struck down a similar measure in North Carolina. The Supreme Court had previously upheld "informed consent" laws for women seeking abortions. The court will hear an abortion case in March, over Louisiana's attempt to require doctors who perform abortions to have admitting privileges at local hospitals. Doctors' speech also has been an issue in non-abortion cases. The federal appeals court in Atlanta struck down parts of a 2011 Florida law that sought to prohibit doctors from talking about gun safety with their patients. Under the law, doctors faced fines and the possible loss of their medical licenses for discussing guns with patients. In Kentucky, doctors must describe the ultrasound in detail while the pregnant woman listens to the fetal heartbeat. Women can avert their eyes and cover their ears to avoid hearing the description or the fetal heartbeat. Doctors failing to comply face fines and can be referred to the state's medical licensing board. The ACLU called the law unconstitutional and unethical. ACLU lawyer Alexa Kolbi-Molinas said that the Supreme Court "has rubber-stamped extreme political interference in the doctor-patient relationship." Pitt painted a different picture of the law. "It's a five-minute procedure that takes place before the abortion is performed to give women who might have a lack of understanding of what's actually in the womb, that this is a real living human being there, they might change their mind," he said. The high court's decision not to review the ultrasound case came on Bevin's final day in office. Bevin, a Republican, is an outspoken abortion opponent. During his term, he signed a series of measures passed by the GOP-led legislature that put limits and conditions on abortion, including the 2017 ultrasound law. Those laws have triggered several legal challenges. Bevin was defeated in last month's election by Democratic Attorney General Andy Beshear, but Republicans remain in control of the state legislature. ___ Associated Press writer Bruce Schreiner contributed to this report from Frankfort, Ky.
answer:
Supreme Court leaves Kentucky's ultrasound law in place.

question:
The Oxford University team's experimental product, called "ChAdOx1 nCoV-19", is a type known as a recombinant viral vector vaccine and is one of at least 70 potential COVID-19 candidate shots under development by biotech and research teams around the world. At least five of those are in preliminary testing in people. The Oxford scientists said on Friday they were recruiting volunteers for early stage - Phase 1 - human trials of their shot, and large-scale production capacity was being put in place "at risk". This means the shots will be produced in large numbers at risk of being useless if trials show they do not work. "We have started at risk manufacturing of this vaccine not just on a smallish scale ... but with a network of manufacturers in as many as seven different places around the world," Adrian Hill, a professor and director of the Jenner Institute at Oxford University, told reporters in an online briefing. "The aim is to have at least a million doses by around about September, when we also hope to have efficacy (trial) results." He said three of the manufacturing partners were in Britain, two in Europe, one in India and one in China. The scientists said initial manufacturing costs would be in "tens of millions" of pounds and acknowledged the investment risk of pressing ahead with production before verification. They did not give details of their financing. More than 2.14 million people have been reported to be infected by the novel coronavirus globally and 143,744 have died, according to a Reuters tally. Hill's team said they plan to start safety and then mid-stage efficacy trials of their potential COVID-19 vaccine in adults aged between 18 and 55 within weeks. They then plan to expand the trial group to older age groups later, and hope to run a final phase trial with around 5,000 volunteers in the late summer. Hill and his co-researchers - including Sarah Gilbert, an Oxford professor of vaccinology - said they have "a high degree of confidence" that human trials of the ChAdOx1 shot will show positive results in protecting against COVID-19 infection. They acknowledged that many other research teams worldwide were also working on potential vaccines, with only a proportion likely to be fully successful. "We can never be certain these things are going to work," Gilbert told the briefing. "My view is that I think this one has a very strong chance of working." Asked when the shot - if proven to work - might be able to be made widely available to the public, Hill said the best case scenario would be for regulators to grant it "emergency use approval" - something that could be achieved within six weeks beyond the point at which data show whether it is effective. That, he said, could mean around six weeks from September, when the team hopes to have positive trial data.
answer:
UK scientists to make a million potential COVID-19 vaccines before proof.